Funded Tech Companies

Rejuvenate Bio

Looking for the VC firms that backed Rejuvenate Bio? Merck Animal Health, Kendall Capital Partners and Digitalis Ventures invested in this innovative life sciences company.

Company Overview

Contact Information

Company Background Information

Overview

At Rejuvenate Bio, we are developing novel therapies to treat aging and age-related diseases through innovative targeted gene therapies. We launched out of George Church's lab at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering at Harvard University.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/8/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Daniel Oliver

        

Chief Medical Officer

Deborah Ascheim

        

Chief Scientific Officer

Noah Davidsohn

        

Co-Founder

George Church

        

Company Investors

• Merck Animal Health
• Kendall Capital Partners
• Digitalis Ventures
• Connecticut Innovations
• VCapital
• California Institute for Regenerative Medicine

Browse more funded tech companies:

Reju | Rejuvenation Technologies

Share this article

About Our Venture Capital Transactions Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary